Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 13, 2017 Filed Sep 14, 2017 23:26 UTC |
GOETZ JOHNEVP, Chief Operating Officer
|
Exercise / conversionBio-Rad A Common Stock | 1,600 | $159.32 | $254,912.00 |
DisclosureSEC source: 0001652252-17-000106 · edgar.xml · nonDerivative · entry 9 GOETZ JOHN · CIK 0001237945 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,861.3235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2017 Filed Sep 14, 2017 23:26 UTC |
GOETZ JOHNEVP, Chief Operating Officer
|
Tax withholdingBio-Rad A Common Stock | 1,320 | $220.47 | $291,020.40 |
DisclosureSEC source: 0001652252-17-000106 · edgar.xml · nonDerivative · entry 8 GOETZ JOHN · CIK 0001237945 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,261.3235 Read SEC document |
| September 13, 2017 Filed Sep 14, 2017 23:26 UTC |
GOETZ JOHNEVP, Chief Operating Officer
|
Exercise / conversionBio-Rad A Common Stock | 1,600 | $139.56 | $223,296.00 |
DisclosureSEC source: 0001652252-17-000106 · edgar.xml · nonDerivative · entry 7 GOETZ JOHN · CIK 0001237945 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,581.3235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2017 Filed Sep 14, 2017 23:26 UTC |
GOETZ JOHNEVP, Chief Operating Officer
|
Tax withholdingBio-Rad A Common Stock | 938 | $220.47 | $206,800.86 |
DisclosureSEC source: 0001652252-17-000106 · edgar.xml · nonDerivative · entry 6 GOETZ JOHN · CIK 0001237945 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,981.3235 Read SEC document |
| September 13, 2017 Filed Sep 14, 2017 23:26 UTC |
GOETZ JOHNEVP, Chief Operating Officer
|
Exercise / conversionBio-Rad A Common Stock | 1,200 | $119.54 | $143,448.00 |
DisclosureSEC source: 0001652252-17-000106 · edgar.xml · nonDerivative · entry 5 GOETZ JOHN · CIK 0001237945 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,919.3235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2017 Filed Sep 14, 2017 23:26 UTC |
GOETZ JOHNEVP, Chief Operating Officer
|
Tax withholdingBio-Rad A Common Stock | 497 | $220.47 | $109,573.59 |
DisclosureSEC source: 0001652252-17-000106 · edgar.xml · nonDerivative · entry 4 GOETZ JOHN · CIK 0001237945 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,719.3235 Read SEC document |
| September 13, 2017 Filed Sep 14, 2017 23:26 UTC |
GOETZ JOHNEVP, Chief Operating Officer
|
Exercise / conversionBio-Rad A Common Stock | 640 | $117.00 | $74,880.00 |
DisclosureSEC source: 0001652252-17-000106 · edgar.xml · nonDerivative · entry 3 GOETZ JOHN · CIK 0001237945 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,216.3235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2017 Filed Sep 14, 2017 23:26 UTC |
GOETZ JOHNEVP, Chief Operating Officer
|
Tax withholdingBio-Rad A Common Stock | 491 | $220.47 | $108,250.77 |
DisclosureSEC source: 0001652252-17-000106 · edgar.xml · nonDerivative · entry 2 GOETZ JOHN · CIK 0001237945 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,576.3235 Read SEC document |
| September 13, 2017 Filed Sep 14, 2017 23:26 UTC |
GOETZ JOHNEVP, Chief Operating Officer
|
Exercise / conversionBio-Rad A Common Stock | 650 | $107.32 | $69,758.00 |
DisclosureSEC source: 0001652252-17-000106 · edgar.xml · nonDerivative · entry 1 GOETZ JOHN · CIK 0001237945 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,067.3235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 22:23 UTC |
Hall ShannonExecutive Vice President
|
Exercise / conversionRestricted Stock Units · Derivative | 240 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000100 · edgar.xml · derivative · entry 3 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 240 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 22:23 UTC |
Hall ShannonExecutive Vice President
|
Tax withholdingBio-Rad A Common Stock | 91 | $218.04 | $19,841.64 |
DisclosureSEC source: 0001652252-17-000100 · edgar.xml · nonDerivative · entry 2 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,809.5691 Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 22:23 UTC |
Hall ShannonExecutive Vice President
|
Exercise / conversionBio-Rad A Common Stock | 240 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000100 · edgar.xml · nonDerivative · entry 1 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,900.5691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 22:18 UTC |
HERTIA JOHNExecutive Vice President
|
Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000098 · edgar.xml · derivative · entry 4 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 22:18 UTC |
HERTIA JOHNExecutive Vice President
|
Tax withholdingBio-Rad A Common Stock | 226 | $218.04 | $49,277.04 |
DisclosureSEC source: 0001652252-17-000098 · edgar.xml · nonDerivative · entry 2 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,562 Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 22:18 UTC |
HERTIA JOHNExecutive Vice President
|
Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000098 · edgar.xml · nonDerivative · entry 1 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 22:14 UTC |
GOETZ JOHNEVP, Chief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 300 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000096 · edgar.xml · derivative · entry 3 GOETZ JOHN · CIK 0001237945 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 22:14 UTC |
GOETZ JOHNEVP, Chief Operating Officer
|
Tax withholdingBio-Rad A Common Stock | 157 | $218.04 | $34,232.28 |
DisclosureSEC source: 0001652252-17-000096 · edgar.xml · nonDerivative · entry 2 GOETZ JOHN · CIK 0001237945 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,417.3235 Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 22:14 UTC |
GOETZ JOHNEVP, Chief Operating Officer
|
Exercise / conversionBio-Rad A Common Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000096 · edgar.xml · nonDerivative · entry 1 GOETZ JOHN · CIK 0001237945 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,574.3235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 21:51 UTC |
Magni GiovanniEVP, Chief Strategy Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 240 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000094 · edgar.xml · derivative · entry 7 Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 240 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. F5 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 21:51 UTC |
Magni GiovanniEVP, Chief Strategy Officer
|
Tax withholdingBio-Rad A Common Stock | 91 | $218.04 | $19,841.64 |
DisclosureSEC source: 0001652252-17-000094 · edgar.xml · nonDerivative · entry 4 Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,651 Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 21:51 UTC |
Magni GiovanniEVP, Chief Strategy Officer
|
Exercise / conversionBio-Rad A Common Stock | 240 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000094 · edgar.xml · nonDerivative · entry 3 Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,742 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 21:47 UTC |
HUTTON RONALD WVice President and Treasurer
|
Exercise / conversionRestricted Stock Units · Derivative | 140 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000092 · edgar.xml · derivative · entry 7 HUTTON RONALD W · CIK 0001248073 · Vice President and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 140 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. F5 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 21:47 UTC |
HUTTON RONALD WVice President and Treasurer
|
Tax withholdingBio-Rad A Common Stock | 53 | $218.04 | $11,556.12 |
DisclosureSEC source: 0001652252-17-000092 · edgar.xml · nonDerivative · entry 4 HUTTON RONALD W · CIK 0001248073 · Vice President and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,449.191 Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 21:47 UTC |
HUTTON RONALD WVice President and Treasurer
|
Exercise / conversionBio-Rad A Common Stock | 140 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000092 · edgar.xml · nonDerivative · entry 3 HUTTON RONALD W · CIK 0001248073 · Vice President and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,502.191 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 21:19 UTC |
STARK JAMES RVP, Corporate Controller
|
Exercise / conversionRestricted Stock Units · Derivative | 200 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000090 · edgar.xml · derivative · entry 7 STARK JAMES R · CIK 0001248083 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. F5 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 21:19 UTC |
STARK JAMES RVP, Corporate Controller
|
Tax withholdingBio-Rad A Common Stock | 76 | $218.04 | $16,571.04 |
DisclosureSEC source: 0001652252-17-000090 · edgar.xml · nonDerivative · entry 4 STARK JAMES R · CIK 0001248083 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 746 Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 21:19 UTC |
STARK JAMES RVP, Corporate Controller
|
Exercise / conversionBio-Rad A Common Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000090 · edgar.xml · nonDerivative · entry 3 STARK JAMES R · CIK 0001248083 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 21:16 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 334 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000088 · edgar.xml · derivative · entry 7 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. F5 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 21:16 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Tax withholdingBio-Rad A Common Stock | 126 | $218.04 | $27,473.04 |
DisclosureSEC source: 0001652252-17-000088 · edgar.xml · nonDerivative · entry 4 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,492 Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 21:16 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Exercise / conversionBio-Rad A Common Stock | 334 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000088 · edgar.xml · nonDerivative · entry 3 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 23:23 UTC |
TSINGOS CHRISTINE AEVP and CFO
|
Exercise / conversionRestricted Stock Units · Derivative | 200 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000104 · edgar.xml · derivative · entry 3 TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 23:23 UTC |
TSINGOS CHRISTINE AEVP and CFO
|
Tax withholdingBio-Rad A Common Stock | 76 | $218.04 | $16,571.04 |
DisclosureSEC source: 0001652252-17-000104 · edgar.xml · nonDerivative · entry 2 TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,683.0979 Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 23:23 UTC |
TSINGOS CHRISTINE AEVP and CFO
|
Exercise / conversionBio-Rad A Common Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000104 · edgar.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,759.0979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 23:07 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 2,617 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000102 · edgar.xml · derivative · entry 6 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad B Common Stock · 2,617 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock. F5 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. F5 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 23:07 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Tax withholdingBio-Rad B Common Stock | 1,366 | $218.04 | $297,842.64 |
DisclosureSEC source: 0001652252-17-000102 · edgar.xml · nonDerivative · entry 3 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,865 Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 23:07 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionBio-Rad B Common Stock | 2,617 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000102 · edgar.xml · nonDerivative · entry 2 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,231 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class B common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 18:37 UTC |
TSINGOS CHRISTINE AEVP and CFO
|
Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000086 · edgar.xml · derivative · entry 7 TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Bio-Rad A Common Stock · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016. F5 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 18:37 UTC |
TSINGOS CHRISTINE AEVP and CFO
|
Exercise / conversionRestricted Stock Units · Derivative | 160 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000086 · edgar.xml · derivative · entry 6 TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160 Underlying: Bio-Rad A Common Stock · 160 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014. F4 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 18:37 UTC |
TSINGOS CHRISTINE AEVP and CFO
|
Tax withholdingBio-Rad A Common Stock | 249 | $218.86 | $54,496.14 |
DisclosureSEC source: 0001652252-17-000086 · edgar.xml · nonDerivative · entry 4 TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,559.0979 Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 18:37 UTC |
TSINGOS CHRISTINE AEVP and CFO
|
Exercise / conversionBio-Rad A Common Stock | 660 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000086 · edgar.xml · nonDerivative · entry 3 TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,808.0979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 18:30 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 3,200 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000084 · edgar.xml · derivative · entry 10 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,600 Underlying: Bio-Rad B Common Stock · 3,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock. F7 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016. F7 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 18:30 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 2,600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000084 · edgar.xml · derivative · entry 9 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,600 Underlying: Bio-Rad B Common Stock · 2,600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock. F6 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014. F6 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 18:30 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Tax withholdingBio-Rad B Common Stock | 3,027 | $218.86 | $662,489.22 |
DisclosureSEC source: 0001652252-17-000084 · edgar.xml · nonDerivative · entry 5 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,614 Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 18:30 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionBio-Rad B Common Stock | 5,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000084 · edgar.xml · nonDerivative · entry 4 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class B common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 18:26 UTC |
HERTIA JOHNExecutive Vice President
|
Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000082 · edgar.xml · derivative · entry 8 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016. F5 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 18:26 UTC |
HERTIA JOHNExecutive Vice President
|
Exercise / conversionRestricted Stock Units · Derivative | 700 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000082 · edgar.xml · derivative · entry 7 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700 Underlying: Bio-Rad A Common Stock · 700 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2013. F4 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2013. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 18:26 UTC |
HERTIA JOHNExecutive Vice President
|
Tax withholdingBio-Rad A Common Stock | 490 | $218.86 | $107,241.40 |
DisclosureSEC source: 0001652252-17-000082 · edgar.xml · nonDerivative · entry 4 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,188 Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 18:26 UTC |
HERTIA JOHNExecutive Vice President
|
Exercise / conversionBio-Rad A Common Stock | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000082 · edgar.xml · nonDerivative · entry 3 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,678 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 18:22 UTC |
Hall ShannonExecutive Vice President
|
Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000080 · edgar.xml · derivative · entry 7 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016. F5 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 18:22 UTC |
Hall ShannonExecutive Vice President
|
Exercise / conversionRestricted Stock Units · Derivative | 240 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000080 · edgar.xml · derivative · entry 6 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240 Underlying: Bio-Rad A Common Stock · 240 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014. F4 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.